241. Hypertyrosinemia type I Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 15 / Drugs : 6 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 3
| Other names | Tyrosinemia type I;Tyrosinemia I;Hereditary tyrosinemia, Type I;Fumarylacetoacetate hydrolase deficiency;FAH deficiency; | ||
|---|---|---|---|
| Disease group | Metabolic diseases | ||
|
Domestic patients
Med expenses recipients (FY2023) |
3 patients Age distribution
 💬 |
||
| Related info (in Japanese) | - | ||
| Clinical research form [April 1, 2025 ~] (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 8-1-2. Tyrosinemia type 1 | ||
| Subtypes | - | ||